Literature DB >> 21839662

Serum insulin-like growth factor-I is negatively associated with serum adiponectin in type 2 diabetes mellitus.

Ippei Kanazawa1, Toru Yamaguchi, Toshitsugu Sugimoto.   

Abstract

BACKGROUND: Although insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone-sulfate (DHEA-S) are involved in age-related diseases such as cardiovascular disease and diabetes mellitus, the association of these hormones with serum adiponectin level is still unclear. OBJECTIVE AND METHODS: To investigate the association between serum IGF-I and DHEA-S versus adiponectin, we conducted a cross-sectional study of 348 Japanese men with type 2 diabetes mellitus and examined their relationships. Serum total adiponectin level was measured by an ELISA kit.
RESULTS: Simple correlation analysis showed that patients' age and duration of diabetes were negatively correlated with IGF-I and DHEA-S (p<0.01) and positively with adiponectin (p<0.01), while body mass index (BMI) was positively correlated with IGF-I and DHEA-S (p<0.001) and negatively with adiponectin (p<0.001). IGF-I was negatively correlated with adiponectin (r=-0.25, p<0.001) and DHEA-S was negatively correlated with adiponectin and HbA1c (r=-0.17, p=0.003 and r=-0.12, p=0.027, respectively). In multiple regression analysis adjusted for age, duration of diabetes, BMI, and serum creatinine, HbA1c was negatively associated with IGF-I and DHEA-S (β=-0.12, p=0.036 and β=-0.22, p<0.001, respectively). Adiponectin was negatively associated with IGF-I (β=-0.15, p=0.013), but not DHEA-S. Moreover, this association was still significant after additional adjustment for HbA1c (β=-0.18, p=0.005).
CONCLUSIONS: Present cross-sectional study for the first time showed a negative association of serum IGF-I with serum adiponectin in Japanese men with type 2 diabetes independent of age, duration of diabetes, BMI, renal function, and HbA1c.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839662     DOI: 10.1016/j.ghir.2011.07.004

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  10 in total

1.  A Prospective Analysis of Plasma Adiponectin and Risk of Incident Cancer: The Dallas Heart Study.

Authors:  Muhammad Shaalan Beg; Sadia Saleem; Aslan Turer; Colby Ayers; James A de Lemos; Amit Khera; Philipp E Scherer; Susan G Lakoski
Journal:  J Natl Compr Canc Netw       Date:  2015-07       Impact factor: 11.908

2.  Adiponectin (ADIPOQ) rs2241766 G/T polymorphism is associated with risk of cancer: evidence from a meta-analysis.

Authors:  Wei Zhou; Yi Liu; De-Wu Zhong
Journal:  Tumour Biol       Date:  2012-11-11

Review 3.  Review: adiponectin in retinopathy.

Authors:  Zhongjie Fu; Yan Gong; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Biochim Biophys Acta       Date:  2016-05-04

4.  Coffee consumption and risk of prostate cancer: an up-to-date meta-analysis.

Authors:  S Zhong; W Chen; X Yu; Z Chen; Q Hu; J Zhao
Journal:  Eur J Clin Nutr       Date:  2013-12-04       Impact factor: 4.016

Review 5.  Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus.

Authors:  Min Sun Kim; Dae-Yeol Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-06-30

Review 6.  A Functional Interplay between IGF-1 and Adiponectin.

Authors:  Stefania Orrù; Ersilia Nigro; Annalisa Mandola; Andreina Alfieri; Pasqualina Buono; Aurora Daniele; Annamaria Mancini; Esther Imperlini
Journal:  Int J Mol Sci       Date:  2017-10-14       Impact factor: 5.923

Review 7.  Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis.

Authors:  Ardeshir Moayeri; Mahmoud Mohamadpour; Seyedeh Fatemeh Mousavi; Ehsan Shirzadpour; Safoura Mohamadpour; Mansour Amraei
Journal:  Ther Clin Risk Manag       Date:  2017-04-11       Impact factor: 2.423

Review 8.  The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes.

Authors:  Natalie J Haywood; Thomas A Slater; Connor J Matthews; Stephen B Wheatcroft
Journal:  Mol Metab       Date:  2018-10-24       Impact factor: 7.422

9.  High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study.

Authors:  Ling Oei; M Carola Zillikens; Abbas Dehghan; Gabriëlle H S Buitendijk; Martha C Castaño-Betancourt; Karol Estrada; Lisette Stolk; Edwin H G Oei; Joyce B J van Meurs; Joseph A M J L Janssen; Albert Hofman; Johannes P T M van Leeuwen; Jacqueline C M Witteman; Huibert A P Pols; André G Uitterlinden; Caroline C W Klaver; Oscar H Franco; Fernando Rivadeneira
Journal:  Diabetes Care       Date:  2013-01-11       Impact factor: 19.112

10.  Manipulation of Dietary Amino Acids Prevents and Reverses Obesity in Mice Through Multiple Mechanisms That Modulate Energy Homeostasis.

Authors:  Chiara Ruocco; Maurizio Ragni; Fabio Rossi; Pierluigi Carullo; Veronica Ghini; Fabiana Piscitelli; Adele Cutignano; Emiliano Manzo; Rafael Maciel Ioris; Franck Bontems; Laura Tedesco; Carolina M Greco; Annachiara Pino; Ilenia Severi; Dianxin Liu; Ryan P Ceddia; Luisa Ponzoni; Leonardo Tenori; Lisa Rizzetto; Matthias Scholz; Kieran Tuohy; Francesco Bifari; Vincenzo Di Marzo; Claudio Luchinat; Michele O Carruba; Saverio Cinti; Ilaria Decimo; Gianluigi Condorelli; Roberto Coppari; Sheila Collins; Alessandra Valerio; Enzo Nisoli
Journal:  Diabetes       Date:  2020-08-10       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.